FDA inspection
MP Biomedicals Asia Pacific Pte Ltd: FDA inspection ending Mar 21, 2025
FDA inspection 1265006 · Voluntary Action Indicated (VAI) · Singapore
Key facts
| Inspection ID | 1265006 |
|---|---|
| Firm | MP Biomedicals Asia Pacific Pte Ltd |
| FEI number | 3008819649 |
| Address | 2 Pioneer Place, Mp Biomedicals Headquarters |
| City | Singapore |
| Country | Singapore |
| Fiscal year | 2025 |
| Inspection end date | Mar 21, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data